Pall - AcroPrep™
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

14

Aug 2020

TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide

TFF Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform today announced that it has entered into a worldwide exclusive licensing agreement with UNION therapeu...

14

Aug 2020

AGC Biologics enters into a partnership as CDMO with Ono Pharmaceuticals

AGC Biologics a global biopharmaceutical contract manufacturing and development organization CDMO announced its partnership with Ono Pharmaceutical Co Ltd ONO to carry out the manufacturing of New and innovative biopharmaceutical products in clinical development phase ONO is an RDoriented pharmaceut...

13

Aug 2020

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

QBiotics Group Limited QGL a life sciences company developing novel anticancer and wound healing pharmaceuticals is pleased to announce that it has entered into an agreement with MSD tradename of Merck Co Inc Kenilworth NJ USA to evaluate use of its lead molecule tigilanol tiglate in combination wi...

13

Aug 2020

GeneCentric Therapeutics Enters into Research Collaboration with Janssen on Genomic Drug Response Biomarkers for Non-Muscle Invasive Bladder Cancer

GeneCentric Therapeutics announced it has entered into a research collaboration with Janssen Research Development LLC Janssen around RNAbased drug response biomarkers for nonmuscle invasive bladder cancer NMIBC

press releasesRead more...

14

Aug 2020

Prometheus Biosciences and Dr. Falk Pharma GmbH Announce Global Collaboration Agreement to Develop and Commercialize a Novel IBD Antibody

Prometheus Biosciences Inc Prometheus a biopharmaceutical company committed to the discovery development and commercialization of a broad portfolio of novel precision therapeutics and companion diagnostics for patients living with significant unmet medical needs in inflammatory bowel disease and Dr...

14

Aug 2020

Isofol enters licensing agreement with Solasia to develop and commercialize arfolitixorin in Japan

Isofol Medical AB announced that it entered into a license agreement with Solasia Pharma KK Solasia TSE a specialized oncology company headquartered in Japan to develop and commercialize Isofols proprietary latestage drug candidate arfolitixorin in Japan

13

Aug 2020

Monopar Announces Plan to Advance Development of Novel Triage Test for Severe COVID-19 Utilizing its Patented Technology

Monopar Therapeutics Inc announced its plan to develop a test to potentially triage COVID patients into those likely versus unlikely to progress to severe respiratory failure The test would use Monopars proprietary monoclonal antibody ATN to detect soluble urokinase plasminogen activator receptor su...

13

Aug 2020

Cytovia Therapeutics Licenses Productivity-Boosting Manufacturing Technology for Its NK Engager Multifunctional Antibodies From ProteoNic

Cytovia Therapeutics Inc Cytovia an emerging biopharmaceutical company developing CAR NK cell therapy and NK engager antibodies for cancer announced that it has licensed from ProteoNic BV its G UNic technology for boosting recombinant protein production allowing for costeffective manufacturing at la...

EventsRead more...

19 - 21

Aug 2020

Patients as Partners US

The Conference Forum
-

19 - 20

Aug 2020

24 - 26

Aug 2020

TOP ARTICLES

  • 4

    Laser Vaccine Adjuvants

    Vaccine adjuvants represent an essential tool to augment human immune response Despite significant advances in...

KNOWLEDGE BANK

  • Interviews

    Thomson Reuters

    Senior Vice President

    We believe publications such as Pharmafocus Asia are essential in providing professionals with insights into the dynamic and evolving trends of the Pharma industry
  • Articles

    Electronic Counters for Bottle Filling

    When a label on a bottle says tablets we assume there are tablets inside dont we Not or but exactly To be more precise it is expected that the bottle contains exactly undamaged tablets of the same kind Obviously bottle filling technology must meet two bigger requirements namely high accuracy filling and the quality of filled products

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...